• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib.

作者信息

Narayanan Vignesh, Honce M Justin, Mehrotra Sanjana, Camidge D Ross

机构信息

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.

Department of Radiology, University of Colorado School of Medicine, Aurora, CO.

出版信息

Clin Lung Cancer. 2016 Jan;17(1):85-90. doi: 10.1016/j.cllc.2015.07.003. Epub 2015 Jul 30.

DOI:10.1016/j.cllc.2015.07.003
PMID:26314227
Abstract
摘要

相似文献

1
Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib.在接受克唑替尼治疗的间变性淋巴瘤激酶基因重排的非小细胞肺癌患者中发生的脑囊性转移瘤
Clin Lung Cancer. 2016 Jan;17(1):85-90. doi: 10.1016/j.cllc.2015.07.003. Epub 2015 Jul 30.
2
Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer.克唑替尼治疗ALK重排转移性非小细胞肺癌脑转移的有效给药方案。
J Thorac Oncol. 2013 Dec;8(12):e112-3. doi: 10.1097/JTO.0000000000000038.
3
Xanthogranulomatous pyelonephritis complicating crizotinib treatment of an ALK-rearranged non-small-cell lung cancer.克唑替尼治疗ALK重排非小细胞肺癌并发黄色肉芽肿性肾盂肾炎
Diagn Interv Imaging. 2018 Apr;99(4):267-268. doi: 10.1016/j.diii.2018.01.008. Epub 2018 Feb 19.
4
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer.克唑替尼作为先前接受过治疗的间变性淋巴瘤激酶重排非小细胞肺癌患者的靶向个体化替代治疗药物。
Drug Des Devel Ther. 2015 Oct 3;9:5491-7. doi: 10.2147/DDDT.S91988. eCollection 2015.
5
Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases.克唑替尼治疗晚期ALK重排非小细胞肺癌合并脑转移患者的临床经验
J Clin Oncol. 2015 Jun 10;33(17):1881-8. doi: 10.1200/JCO.2014.59.0539. Epub 2015 Jan 26.
6
Long-lasting response to third-line crizotinib treatment in a patient with non-small cell lung cancer with brain metastases and poor performance status.一位非小细胞肺癌伴脑转移和较差体力状态患者接受三线克唑替尼治疗后获得持久缓解。
Thorac Cancer. 2016 Sep;7(5):619-622. doi: 10.1111/1759-7714.12383. Epub 2016 Aug 12.
7
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.克唑替尼耐药的间变性淋巴瘤激酶（ALK）重排非小细胞肺癌（NSCLC）患者中艾乐替尼针对全身疾病和脑转移的安全性和活性：一项 1/2 期研究剂量探索部分的结果。
Lancet Oncol. 2014 Sep;15(10):1119-28. doi: 10.1016/S1470-2045(14)70362-6. Epub 2014 Aug 18.
8
Efficacy of crizotinib inhibiting specific molecular pathways in non-small-cell lung carcinoma.克唑替尼抑制非小细胞肺癌中特定分子途径的疗效。
Expert Rev Anticancer Ther. 2015 Apr;15(4):375-85. doi: 10.1586/14737140.2015.1025761.
9
Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib.克唑替尼治疗后发生EML4-ALK易位的非小细胞肺癌中的脑囊性转移瘤
J Thorac Oncol. 2015 Jul;10(7):1116-7. doi: 10.1097/JTO.0000000000000409.
10
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?].[间变性淋巴瘤激酶（ALK）重排的非小细胞肺癌：如何在常规实践中优化克唑替尼治疗？]
Bull Cancer. 2014 Sep;101(9):823-31. doi: 10.1684/bdc.2014.1976.

引用本文的文献

1
Extensive Stage Small-Cell Lung Cancer with Cystic Brain Metastases: A Report of Two Cases.广泛期小细胞肺癌伴脑囊性转移：两例报告
Cancer Manag Res. 2024 Mar 18;16:177-183. doi: 10.2147/CMAR.S449841. eCollection 2024.
2
Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.非小细胞肺癌患者实性和囊性脑转移瘤的治疗与预后
Cancer Manag Res. 2021 Aug 10;13:6309-6317. doi: 10.2147/CMAR.S314060. eCollection 2021.
3
Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists.
酪氨酸激酶抑制剂治疗非小细胞肺癌脑转移：放射科医生的入门指南。
AJNR Am J Neuroradiol. 2020 May;41(5):738-750. doi: 10.3174/ajnr.A6477. Epub 2020 Mar 26.
4
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.劳拉替尼挽救了一名先前接受过克唑替尼和高剂量布加替尼治疗的ALK阳性非小细胞肺癌患者的中枢神经系统复发。
Clin Lung Cancer. 2019 Mar;20(2):e133-e136. doi: 10.1016/j.cllc.2018.11.010. Epub 2018 Nov 29.
5
Cystic brain metastases in ALK-rearranged non-small cell lung cancer.ALK重排非小细胞肺癌中的脑囊性转移瘤。
Ecancermedicalscience. 2018 Mar 14;12:818. doi: 10.3332/ecancer.2018.818. eCollection 2018.
6
Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.囊性脑转移与晚期乳腺癌患者的预后不良相关。
Oncotarget. 2016 Nov 8;7(45):74006-74014. doi: 10.18632/oncotarget.12176.
7
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer.克唑替尼作为先前接受过治疗的间变性淋巴瘤激酶重排非小细胞肺癌患者的靶向个体化替代治疗药物。
Drug Des Devel Ther. 2015 Oct 3;9:5491-7. doi: 10.2147/DDDT.S91988. eCollection 2015.